Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2026-04-23 @ 2:16 PM
Study NCT ID:
NCT04611802
Status:
COMPLETED
Last Update Posted:
2023-12-21
First Post:
2020-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2
Sponsor:
Novavax
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
2019nCoV-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | FED | View |